Case 3: Kaposi's Sarcoma

Case-Based Modules
Initial Evaluation
Dermatologic Manifestations
Oral Manifestations
OIs: Prophylaxis
OIs: Treatment
Antiretroviral Rx
Antiretroviral Rx: Resistance
Antiretroviral Rx: Adverse Effects
Drug-Drug Interactions
Postexposure Prophylaxis
Perinatal Transmission
Special Populations
Prevention for Positives
Challenging Unknowns
Interactive Tutorials
This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.

Home
About This Site
Free CME
AETC NRC
Resources
Feedback
Site Map
Authors

Question | Discussion | References | CME Credit

You answered:

	Liquid nitrogen cryotherapy is generally ineffective for management of localized cutaneous Kaposi's sarcoma lesions.

This answer is incorrect. Cutaneous Kaposi's sarcoma lesions can be treated by liquid nitrogen cryotherapy, intralesional chemotherapy, radiation therapy, or a combination of these modalities. The choice of therapeutic options depends on the pattern of involvement in the individual patient.

	In some patients, highly active antiretroviral therapy alone causes significant improvement of Kaposi's sarcoma lesions.
	Human herpes virus type 6 (HHV-6) is the causative agent of Kaposi's sarcoma.
	Visceral, but not isolated cutaneous Kaposi's sarcoma, is an AIDS-defining illness.

[Back to Case 3 Question | Go to Correct Answer]